介入性心臟學設備的全球市場 - COVID-19:2021年∼2027年 (MedSuite)
Global Interventional Cardiology Market Analysis - COVID19 - 2021-2027 - MedSuite
Throughout this medical market research, the publisher analyzed 46 interventional cardiology companies across the globe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of global Interventional Cardiology Device Market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Global technologies, such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed.
Boston Scientific was the leading competitor in the global market for interventional cardiology devices in 2020. The company was the market leader in coronary balloon catheters, coronary embolic protection devices, and coronary atherectomy devices markets. Boston Scientific offers the Maverick™, Apex™, and Emerge® PTCA devices, as well as the Flextome™ cutting balloon catheter.
Overall, the global interventional cardiology market was valued at approximately $11.1 billion in 2020, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market value is expected to reach $16.2 billion in 2027.
Report Regional Coverage:
Throughout this research series, the publisher has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are: